Copper-Chelating Tripeptide / Tissue-Repair Research Compound
GHK-Cu Copper Peptide — Research Compound
As of 2026-08-23, DMV Research lists GHK-Cu (CAS 89030-95-5) and publishes 1 third-party certificate of analysis for it, for laboratory research use only.
GHK-Cu (glycyl-L-histidyl-L-lysine copper(II) complex; CAS 89030-95-5; MW 340.38 Da) is a naturally occurring copper-chelating tripeptide first isolated from human plasma albumin in 1973 by Loren Pickart. It is present in human plasma (~200 ng/mL in young adults), saliva and urine, and declines with age — a pattern that has motivated research into its roles in tissue repair, collagen biology and inflammatory signaling. The copper(II) ion is held in a square-planar coordination by the imidazole nitrogen of histidine and the α-amino nitrogens of glycine and histidine; that coordination is what distinguishes GHK-Cu from the free GHK tripeptide. It is supplied as a lyophilized powder for laboratory research applications. Research use only.
For laboratory research use only. Not for human or veterinary use. Not for diagnostic or therapeutic use. Not a drug, food, cosmetic, or dietary supplement.
Compound identity
- Name
- GHK-Cu
- Class
- Copper-Chelating Tripeptide / Tissue-Repair Research Compound
- CAS number
- 89030-95-5
- Molecular formula
- C14H24CuN6O4
- Also known as
- Copper Peptide GHK-Cu, copper peptides, copper peptide research, copper tripeptide-1, copper tripeptide research, Glycyl-L-histidyl-L-lysine copper, glycyl-histidyl-lysine copper, GHK copper peptide, copper binding peptide, GHK-Cu skin research, tissue repair peptide research
- Sequence
- Gly-His-Lys (copper complex)
Research context
GHK-Cu's research mechanisms span several distinct biological axes: (1) **Collagen synthesis** — GHK-Cu stimulates collagen synthesis in fibroblast cultures (documented by multiple independent groups) via TGF-β1 upregulation and direct effects on fibroblast collagen gene expression; (2) **Tissue repair** — in rodent models, topical and systemic GHK-Cu accelerates wound closure, granulation tissue formation and re-epithelialization; (3) **Angiogenesis** — GHK-Cu stimulates VEGF and FGF-2 expression in fibroblasts and endothelial cells, promoting neovascularization in healing tissue; (4) **Inflammatory signaling** — GHK-Cu modulates TGF-β1-driven fibrosis (TGF-β1 at low concentrations stimulates collagen and at high concentrations drives fibrosis; GHK-Cu shifts the balance toward the repair direction); (5) **Antioxidant chemistry** — the Cu(II) complex has superoxide dismutase-like activity, scavenging reactive oxygen species in the culture environment. All of this is preclinical; GHK-Cu is not approved for any therapeutic indication.
GHK-Cu also has an active research record in skin biology and cellular-aging models. Published studies using fibroblast cultures and ex vivo skin models show GHK-Cu upregulates decorin, lumican and collagen-associated proteoglycans (extracellular-matrix components that maintain skin architecture), and stimulates TIMP-1 and TIMP-2 (inhibitors of the matrix metalloproteinases that degrade collagen). In-vitro work has also shown broad effects on gene expression — Pickart et al. and later Maquart's group published microarray data suggesting GHK-Cu modulates the expression of hundreds of genes involved in tissue remodeling, inflammation and cell proliferation in fibroblasts. That broad footprint is consistent with GHK-Cu acting as a natural tissue-remodeling signal rather than a receptor-targeted compound.
For researchers handling GHK-Cu: the compound is supplied as the copper(II) complex, which carries the characteristic blue-green colour of coordinated Cu(II). Stability is excellent in lyophilized form; in aqueous solution, pH and copper oxidation state matter (acidic pH preserves Cu(II)). The free peptide GHK (CAS 49557-75-7, without copper) retains some activity but substantially less in collagen-synthesis and tissue-repair assays — copper coordination appears essential for full activity. GHK-Cu should not be confused with free GHK, or with the synthetic copper peptides used in cosmetic formulations, which may differ in composition. DMV Research supplies GHK-Cu with a per-batch third-party Certificate of Analysis confirming identity and ≥99% purity by HPLC. Research use only.
Related research
GHK-Cu is profiled alongside DMV Research's other copper-chelating tripeptide overviews, including BPC-157, TB-500 peptide, Thymosin Beta-4, BPC-157 + TB-500 Stack (Research Overview), Follistatin 344, KPV, and Myostatin Inhibitor Peptides — Follistatin & Muscle Research Hub — each with its own identity data, cited literature, and FAQ. See the product listing for current pricing and the GHK-Cu Certificate of Analysis for lab-verified purity data.
Frequently asked questions
What is GHK-Cu?+
GHK-Cu (glycyl-L-histidyl-L-lysine copper(II) complex, CAS 89030-95-5, MW 340.38 Da) is a naturally occurring copper-chelating tripeptide, first isolated from human plasma albumin by Loren Pickart in 1973. It is found at ~200 ng/mL in the plasma of young adults and declines with age. It is used as a research reference compound in collagen, tissue-repair and angiogenesis models. Research use only.
How does GHK-Cu affect collagen synthesis in research models?+
GHK-Cu stimulates collagen synthesis in fibroblast cultures through several routes: upregulation of TGF-β1 at low, pro-repair concentrations, direct effects on fibroblast collagen gene expression, and upregulation of proteoglycans (decorin, lumican) that support extracellular-matrix architecture. The copper(II) coordination appears essential — free GHK without copper shows substantially reduced collagen-stimulating activity. Research use only.
What tissue-repair models have used GHK-Cu?+
Rodent excisional and incisional models have shown that topical and systemic GHK-Cu accelerates wound closure, granulation tissue formation and re-epithelialization. In-vitro fibroblast scratch assays show enhanced migration and proliferation. Additional models include delayed repair in diabetic rodents as a disease model. All of this research is preclinical; GHK-Cu is not FDA-approved for any therapeutic indication. Research use only.
How is GHK-Cu different from free GHK peptide?+
GHK-Cu is the copper(II) complex of the GHK tripeptide — copper coordinated in a square-planar complex with the imidazole nitrogen (His) and the α-amino nitrogens (Gly, His). This coordination is essential for full activity. Free GHK (CAS 49557-75-7) retains some activity in gene-expression studies but substantially less in collagen-synthesis and tissue-repair assays. Research protocols should state which form is used.
Why is GHK-Cu blue?+
The characteristic blue-green colour comes from the copper(II) ion coordinated by the GHK tripeptide — a property of the copper complex, and a quick visual check that the material is the complex rather than the free peptide.
Is GHK-Cu approved for human use?+
No. As supplied by DMV Research, GHK-Cu is a research chemical for laboratory use only, not for human consumption.
What purity is the GHK-Cu research peptide?+
Each batch is independently tested to 99%+ purity, with a Certificate of Analysis available per batch.
Research use only
All products are intended for laboratory and research use only (RUO) and are not for human consumption, ingestion, or any in-vivo use.
The statements on this page have not been evaluated by the FDA. For laboratory research use only. Not for human or veterinary use. Not for diagnostic or therapeutic use. Not a drug, food, cosmetic, or dietary supplement.
